ETR:SBS

Stratec SE (SBS.F) Stock Forecast, Price & News

€135.40

+3.40 (+2.58 %)

(As of 01/22/2021 12:00 AM ET)

Add

Compare

Today's Range

€130.80

Now: €135.40▼

€136.00

50-Day Range

€114.20

MA: €121.61▼

€132.00

52-Week Range

€46.40

Now: €135.40▼

€144.60

Volume9,975 shs

Average Volume6,253 shs

Market Capitalization$1.64 billion

P/E Ratio72.29

Dividend Yield0.64%

BetaN/A

STRATEC SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates in three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technology. STRATEC SE also develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to STRATEC SE in December 2018. STRATEC SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

MarketRank^™

Overall MarketRank^™

1.00 out of 5 stars

1.3 Analyst's Opinion

Consensus Rating
Stratec SE (SBS.F) has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, no hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of €121.75, Stratec SE (SBS.F) has a forecasted downside of 10.1% from its current price of €135.40.
Amount of Analyst Coverage
Stratec SE (SBS.F) has only been the subject of 3 research reports in the past 90 days.

2.9 Community Rank

Outperform Votes
Stratec SE (SBS.F) has received 150 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Stratec SE (SBS.F) has received 112 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Stratec SE (SBS.F) has received 57.25% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Stratec SE (SBS.F) and other stocks. Vote “Outperform” if you believe SBS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SBS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.8 Dividend Strength

Dividend Yield
Stratec SE (SBS.F) has a dividend yield of 0.64%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Stratec SE (SBS.F) does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Stratec SE (SBS.F) is 44.85%. This payout ratio is at a healthy, sustainable level, below 75%.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Stratec SE (SBS.F) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Stratec SE (SBS.F) is 72.29, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.30.
Price to Earnings Ratio vs. Sector
The P/E ratio of Stratec SE (SBS.F) is 72.29, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.31.
Price to Book Value per Share Ratio
Stratec SE (SBS.F) has a P/B Ratio of 10.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange ETR

Industry Medical Devices

Sub-IndustryN/A

SectorMedical

Current SymbolETR:SBS

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.stratec.com

Phone+49-7082-79160

Employees1,315

Debt

Debt-to-Equity Ratio63.93

Current Ratio3.65

Quick Ratio1.94

Price-To-Earnings

Trailing P/E Ratio72.29

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$242.39 million

Price / Sales6.76

Cash Flow€2.57 per share

Price / Cash Flow52.65

Book Value€13.41 per share

Price / Book10.10

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares12,102,900

Market Cap$1.64 billion

Next Earnings Date3/31/2021 (Estimated)

OptionableOptionable

€135.40

+3.40 (+2.58 %)

(As of 01/22/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive SBS News and Ratings via Email

Sign-up to receive the latest news and ratings for SBS and its competitors with MarketBeat's FREE daily newsletter.

Stratec SE (SBS.F) (ETR:SBS) Frequently Asked Questions

How has Stratec SE (SBS.F)'s stock price been impacted by Coronavirus (COVID-19)?

Stratec SE (SBS.F)'s stock was trading at €64.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SBS stock has increased by 111.6% and is now trading at €135.40.
View which stocks have been most impacted by COVID-19.

Is Stratec SE (SBS.F) a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stratec SE (SBS.F) in the last twelve months. There are currently 1 sell rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Stratec SE (SBS.F) stock.
View analyst ratings for Stratec SE (SBS.F) or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Stratec SE (SBS.F)?

Wall Street analysts have given Stratec SE (SBS.F) a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Stratec SE (SBS.F) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Stratec SE (SBS.F)'s next earnings date?

Stratec SE (SBS.F) is scheduled to release its next quarterly earnings announcement on Wednesday, March 31st 2021.
View our earnings forecast for Stratec SE (SBS.F).

Is Stratec SE (SBS.F) a good dividend stock?

Stratec SE (SBS.F) pays an annual dividend of €0.84 per share and currently has a dividend yield of 0.64%. The dividend payout ratio of Stratec SE (SBS.F) is 44.85%. This payout ratio is at a healthy, sustainable level, below 75%.
View Stratec SE (SBS.F)'s dividend history.

What price target have analysts set for SBS?

4 analysts have issued twelve-month price objectives for Stratec SE (SBS.F)'s stock. Their forecasts range from €98.00 to €136.00. On average, they expect Stratec SE (SBS.F)'s share price to reach €121.75 in the next year. This suggests that the stock has a possible downside of 10.1%.
View analysts' price targets for Stratec SE (SBS.F) or view Wall Street analyst' top-rated stocks.

Who are some of Stratec SE (SBS.F)'s key competitors?

Some companies that are related to Stratec SE (SBS.F) include Convatec Group Plc (CTEC.L) (CTEC), Drägerwerk AG & Co. KGaA (DRW3.F) (DRW3), Viemed Healthcare, Inc. (VMD.TO) (VMD), Avacta Group Plc (AVCT.L) (AVCT), Viemed Healthcare (VMD), Creo Medical Limited (CREO.L) (CREO), Titan Medical Inc. (TMD.TO) (TMD), Hamilton Thorne Ltd. (HTL.V) (HTL), Advanced Oncotherapy plc (AVO.L) (AVO), Medica Group Plc (MGP.L) (MGP), Polarean Imaging plc (POLX.L) (POLX), Xtant Medical (XTNT), Protech Home Medical Corp. (PTQ.V) (PTQ), Kromek Group plc (KMK.L) (KMK) and Inspiration Healthcare Group plc (IHC.L) (IHC).
View all of SBS's competitors.

What other stocks do shareholders of Stratec SE (SBS.F) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stratec SE (SBS.F) investors own include Great Portland Estates Plc (GPOR.L) (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), 186808 (CHC), Bio-Rad Laboratories (BIO), Berkshire Hills Bancorp (BHLB), ASGN (ASGN), Apptio (APTI) and Anadarko Petroleum (APC).

Who are Stratec SE (SBS.F)'s key executives?

Stratec SE (SBS.F)'s management team includes the following people:

Mr. Marcus Wolfinger, Chairman of Board of Management & CEO (Age 53, Pay $590k)
Dr. Robert Siegle, Director of Fin. & HR and Member of Board of Management (Age 53, Pay $479k)
Dr. Claus Vielsack, Director of Product Devel. & Member of Board of Management (Age 53, Pay $413k)
Mr. Hermann Leistner, Founder & Advisor (Age 74)
Mr. Jan Keppeler, Head of Investor Relations & Corp. Communications
Mr. Andre Loy, Director of Corp. Communications
Mr. Roland Utz, Head of Supply Chain Management & Sr. VP

What is Stratec SE (SBS.F)'s stock symbol?

Stratec SE (SBS.F) trades on the ETR under the ticker symbol "SBS."

What is Stratec SE (SBS.F)'s stock price today?

One share of SBS stock can currently be purchased for approximately €135.40.

How big of a company is Stratec SE (SBS.F)?

Stratec SE (SBS.F) has a market capitalization of $1.64 billion and generates $242.39 million in revenue each year. Stratec SE (SBS.F) employs 1,315 workers across the globe.

What is Stratec SE (SBS.F)'s official website?

The official website for Stratec SE (SBS.F) is www.stratec.com.

How can I contact Stratec SE (SBS.F)?

Stratec SE (SBS.F)'s mailing address is Gewerbestr. 37, BIRKENFELD, 75217, Germany. The company can be reached via phone at +49-7082-79160.

This page was last updated on 1/23/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here